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httpType 1 endoleaks following endovascular aortic aneurysm repair are associated with poor outcomes and
re-intervention is recommended as soon as possible after diagnosis. When standard endovascular or surgical
treatment options are unsuitable due to severe co-morbidity or adverse anatomic factors, patients can be treated
by transcatheter embolisation of the endoleak itself. We describe six such patients with proximal and distal type
1 endoleaks, who have been successfully treated by transcatheter embolisation with Onyx. The embolisation
technique, advantages of using this relatively novel liquid embolic agent and potential pitfalls are discussed.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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on achieving an adequate proximal and distal seal to
exclude the aneurysm sac from the systemic circulation.
Type 1 endoleaks are associated with an increased risk of
post-procedural aneurysm rupture and late aneurysm-
related death, and re-intervention is recommended as soon
as possible after diagnosis.1
Standard endovascular treatment options for type 1a
endoleaks include the insertion of an aortic cuff to extend
endograft coverage more proximally, or placement of
a large-calibre balloon-expandable stent (e.g. Palmaz or
Sinus) inside the proximal endograft to improve the seal.
Standard therapy for type 1b endoleaks involves distal
extension of endograft coverage.
If an endoleak persists despite these measures, deﬁnitive
therapy may require conventional open surgery, visceral
artery bypass combined with stent-graft extension or the
use of chimney or periscope grafts to extend proximal and
distal landing zones. Patients not eligible for these more
complicated procedures due to severe co-morbidities or
adverse anatomical factors may be treated by transcatheter
embolisation of the endoleak itself.
There is limited published experience of type 1 endoleak
embolisation and previous reports have involved coils2 and
n-butyl 2-cyanoacrylate (n-BCA).3 Onyx (ev3, Irvine, CA,
USA) is a relatively novel non-adhesive liquid embolic agent,
which is most commonly used to treat intracranial arterio-
venous malformations. It is comprised of ethylene vinyl
alcohol dissolved in dimethyl sulphoxide and suspended
micronised tantalum powder to provide contrast for visu-
alisation under ﬂuoroscopy.We describe a small series of six
patients who underwent Onyx embolisation of type 1rresponding author. Tel.: þ44 (0) 20 8725 1160; fax: þ44 (0) 20 8725
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dications to conventional type 1 endoleak management
techniques and open conversion. The clinical details of
these patients are presented below and are summarised in
Table 1.PATIENT 1
A 65-year-old female patient underwent endovascular
repair of a juxtarenal abdominal aortic aneurysm (AAA) with
a Ventana fenestrated aortic endograft (Endologix, Irvine,
CA, USA). The graft moved inferiorly during EVAR resulting
in occlusion of the left renal artery fenestration and
a proximal type 1 endoleak (Fig. 1(a)). Due to the fenes-
trated nature of the device, the usual endovascular tech-
niques for treating type 1 endoleaks were deemed
unsuitable. Therefore, a decision was made to embolise the
endoleak cavity with Onyx.
The presence and location of the type 1a endoleak was
conﬁrmed by aortography. The endoleak entry point was
engaged with a sidewinder catheter and selective angiog-
raphy demonstrated the extent of the endoleak cavity
(Fig. 1(b)). A more stable position was obtained with
a microcatheter and Onyx was injected slowly into endoleak
(Fig. 1(c)) until the entire endoleak cavity including the entry
site was occluded (Fig. 1(d)). A follow-up duplex scan at 6
weeks and a computed tomography (CT) aorta at 3 months
show no evidence of endoleak and stable aneurysm sac size.PATIENT 2
An 82-year-old male patient presented with a proximal type
1 endoleak 12 months after EVAR with a custom-made
42-mm diameter Zenith endograft (W. Cook Europe, Bjae-
verskov, Denmark) for an AAA. The endoleak was unsuitable
for standard treatment options largely due to the oversized
graft diameter.
Following a conﬁrmatory aortogram, the entry site of the
proximal type 1 endoleak was identiﬁed and selectively
Table 1. Summary of patients treated with Onyx embolisation.
No Pathology Initial treatment Endoleak Indication for Onyx
1 Juxtarenal AAA Fenestrated EVAR with Ventana 1a Unsuitable for fenestrated cuff.
Unﬁt for open surgery.
2 Infrarenal AAA EVAR with oversized (42 mm) graft 1a Oversized cuff/stent not available.
Unﬁt for open surgery.
3 Chronic type B dissection &
infrarenal AAA
Hybrid TEVAR with 3 vessel
visceral bypass from right CIA
1b Unsuitable for limb extension due
to R CIA visceral artery bypasses.
4 Descending TAA TEVAR to coeliac origin 1b Unsuitable for hybrid procedure and
fenestrated/branched endografts.
5 Infrarenal AAA Tube graft from outside hospital 1a Infected graft. Unsuitable for fenestrated cuff.
Unﬁt for open surgery.
6 Infrarenal AAA EVAR, short angulated neck 1a Unsuitable for aortic cuff.
Unﬁt for open surgery.
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rysm sac and the endoleak cavity and the entry site were
embolised with 34 ml of Onyx. Follow-up imaging with
duplex ultrasound at 1 month shows no residual endoleak
and stable sac size.PATIENT 3
A 68-year-old male patient underwent hybrid thoracic
endovascular aortic repair (TEVAR) with three visceral
artery bypass grafts arising from the distal right common
iliac artery (CIA) for thoraco-abdominal aortic dissection
and an infrarenal AAA. A 6-year follow-up CT showed
a distal type 1 endoleak from the right CIA above and close
to the origin of the visceral bypass grafts, secondary to
interval dilatation of the right CIA. The usual treatment
option of distal limb extension was not feasible in this case
due to the presence of visceral bypass grafts. Therefore, the
patient was referred for embolisation with Onyx.
Angiogram through a cobra catheter and microcatheter
in the endoleak cavity conﬁrmed communication with the
aortic aneurysm sac. Onyx was injected slowly and carefully
to avoid migration towards the visceral artery bypasses.
Completion angiography conﬁrmed successful abolition of
endoleak and preservation of the visceral bypass grafts.
Duplex follow-up at 1, 3, 7 and 10 months shows no
evidence of endoleak and stable sac size.PATIENT 4
A 79-year-old man underwent TEVAR from the proximal
descending aorta to the coeliac axis origin for a descending
thoracic aortic aneurysm. A CT scan at 2 months showed
a large distal type 1 endoleak with an enlarging aneurysm
sac. The patient was unﬁt for a hybrid solution and
unsuitable for fenestrated/branched endografts.
The endoleak cavity was successfully embolised with 9 ml
of Onyx via a cobra catheter and microcatheter. Completion
angiography showed no residual ﬂow of contrast medium at
the site of the previously seen endoleak. Follow-up CT
images at 6 months were signiﬁcantly marred by a beam-
hardening artefact from the tantalum but the aneurysm sac
has remained stable and a duplex ultrasonography (US)
shows no evidence of endoleak.PATIENT 5
A 62-year-old male who underwent EVAR for an infrarenal
AAA presented 3 years later with an infected graft and type
1a endoleak due to inferior migration of the endograft. The
patient was unﬁt for open surgery or fenestrated cuff.
The endoleak sac was successfully embolised with Onyx and
the aneurysm sac was unchanged on 1-month follow-up
CT scan.
PATIENT 6
A 77-year-old man who underwent previous EVAR for an
infrarenal AAA presented 2 years later with inferior migra-
tion of the stent graft and type 1a endoleak secondary to
a short angulated neck. The patient was not ﬁt for open
repair and the neck morphology was unsuitable for an
aortic cuff. The endoleak was embolised with Onyx and
a follow-up duplex scan at 6 weeks shows no evidence of
endoleak and stable sac size.
DISCUSSION
The published experience of endoleak embolisation with
Onyx is very limited. The largest series reported six patients
who were treated with Onyx embolisation of type 1 endo-
leaks following EVAR.4 The authors reported 100% technical
success, although there were early occlusions of renal
artery chimney grafts in one patient, and another patient
experienced late stent-graft migration resulting in fatal
aneurysm rupture at 18 months post embolisation. Another
study described a single successful case of Onyx embolisa-
tion for a proximal type 1 endoleak following EVAR.5
Our experience with Onyx embolisation has been positive
with no recurrent endoleaks at up to 10 months of follow-
up. The procedure itself is not technically challenging for
operators with sufﬁcient training and expertise in emboli-
sation procedures as the endoleak cavity can be accessed
with relative ease.
However, there are limitations to this technique and Onyx
has its own particular drawbacks. First, Onyx is highly radio-
opaque and the microcatheter tip becomes obscured as the
endoleak cavity is ﬁlled. It is therefore important to be
aware of the location of the microcatheter tip and to
maintain a stable position to avoid the risk of non-target
Figure 1. (a) Completion angiogram following placement of Ventana fenestrated aortic endograft shows a proximal type 1 endoleak
(arrows) and occluded left renal fenestration. (b) Entry into the proximal type 1 endoleak was achieved with a sidewinder catheter (white
arrowheads). Selective angiography demonstrated the extent of the endoleak cavity (black arrows). (c) A more stable position was
obtained within the endoleak cavity with a microcatheter (black arrows). Onyx was injected slowly into the deepest component of the
endoleak initially and the microcatheter tip was subsequently withdrawn gradually during further slow injection. (d) Completion angiogram
shows no residual endoleak after embolisation with 7 ml of Onyx.
J.-Y. Chun, R. Morgan 143embolisation. Second, embolisation is time consuming as
Onyx is currently only available in 1.5-ml vials and it must
be injected slowly. Third, Onyx is expensive and this may be
the determining factor in using alternative embolic agents.
Fourth, the tantalum causes signiﬁcant beam-hardening
artefact on follow-up CT and any residual or recurrent
endoleak may not be visualised. In these cases, the aneu-
rysm sac diameter will be the only reliable indicator and
duplex US may be a better follow-up imaging modality.
Finally, our follow-up period of 10 months is relatively shortand the long-term ability of Onyx to prevent pressurisation
of the aneurysm sac remains to be seen.
In conclusion, Onyx is a useful embolic agent in the
treatment of patients with type 1 endoleaks after EVAR,
who are not suitable for more standard therapeutic options.
The early results of this novel technique are promising and
long-term outcomes are awaited.
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